HOME | 한국어 | Contact Us | Site map |
        news
        faq
        vod
Home > COMMUNITY > news
Articles 35
No.
Subject
Author
35 Overdenture Lecture in Manila Philippine Dentists’ conference (9/6/2019)
kainos
Jul 24, 2019 2469
34 Chinese Patent acquired (19/4/2019)
kainos
Jul 24, 2019 2508
33 IDS2019 participation (2.1 F-067) (12/3/2019)
kainos
Jul 24, 2019 2518
32 ISO13485:2016 acquired (27/2/2019)
kainos
Jul 24, 2019 2448
31 Seminar at Daegu – NeoBiotech invitation (12/11/2016)
kainos
Jan 23, 2017 22722
30 Participation YESDEX booth at Busan (12~13/11/2016)
kainos
Jan 23, 2017 22525
29 Seminar at Daejeon – NeoBiotech invitation (26/10/2016)
kainos
Jan 23, 2017 21833
28 Seminar at Andong – NeoBiotech invitation (19/10/2016)
kainos
Jan 23, 2017 22397
27 Participating NeoBiotech International Seminar booth (9/10/2016)
kainos
Jan 23, 2017 23087
26 Seminar at Pohang – NeoBiotech invitation (24/9/2016)
kainos
Jan 23, 2017 21990
25 Semianr at Daegu – Dentopia invitation (24/8/2016)
kainos
Jan 23, 2017 21836
24 Hands-on seminar at Busan (23/7/2016)
kainos
Jan 23, 2017 23005
23 Dr. Lee spoke at Millenium Seminar at Seoul (17/7/2016)
kainos
Jan 23, 2017 22465
22 VENTURE COMPANY approved (15/7/2016)
kainos
Jan 23, 2017 21807
21 Seminar at Ulsan – WARO MEDICAL invitation (6/7/2016)
kainos
Jan 23, 2017 22515
20 Seminar at Seoul (29/6/2016)
kainos
Jan 23, 2017 21292
19 Seminar at Changwon – WARO MEDICAL invitation (25/6/2016)
kainos
Jan 23, 2017 21535
18 Hands-on Seminar at Busan (22/6/2016)
kainos
Jan 23, 2017 21193
17 Semianr at Yanbian China (19/6/2016)
kainos
Jan 23, 2017 21367
16 Seminar at Changwon – WARO MEDICAL invitation (15/6/2016)
kainos
Jan 23, 2017 21211
COPYRIGHT © SNAFFIT. ALL RIGHTS RESERVED

SNAFFIT : 302 Sinhyeong Bldg. 824 Daewangpangyo-ro Sujeong-Gu, Seongnam City, Gyeonggi-DO, Korea 461-370 | Tel : 031-609-1621 , Fax : 070-7609-4421

E-mail : snaffit@snaffit.com
PRODUCTS
Design Concept
Products
Procedure
Manual
CLINICAL CASES
Clinical Cases
PARTNERSHIP
Distributors
Partners
COMPANY
About
Patent
Contact US
COMMUNITY
News
FAQ
VOD